Thyroid cancer is the fastest increasing cancer worldwide in all age groups. Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer in both adults and children. PTC genomic landscape has been extensively studied in adults, but information regarding sporadic pediatric patients is lacking. Although BRAF V600E mutation is highly prevalent in adults, this mutation is uncommon in pediatric cases. As adult and pediatric PTC is a mitogen-activated protein kinase-driven cancer, this altered pathway might be activated by different genetic events. The aim of this study was to investigate the occurrence of AGK-BRAF fusion gene, recently described in radiation-exposed pediatric PTC, in a cohort of exclusively sporadic pediatric PTC...
Context: BRAF V600E is considered a primary event, a negative prognostic marker, and a site for phar...
International audienceBACKGROUND: Papillary thyroid carcinoma (PTC) in young people usually has an a...
Papillary thyroid cancer (PTC) constitutes more than 90 % of the thyroid cancers. MAP kinase/ERK pat...
Background: Previous studies reported significant differences in the clinical presentation and outco...
The incidence of thyroid carcinoma, mainly of the papillary histological subtype (PTC), has increase...
There has been little understanding of the molecular pathogenesis of pediatric thyroid cancers. Most...
Papillary thyroid carcinoma (PTC) presents distinct clinico-pathological and molecular differences i...
ntroduction: Follicular-derived differentiated thyroid carcinoma (DTC) is the most common endocrine ...
Activating mutations of BRAF have been identified in a variety of human cancers, most notably melano...
none12siBACKGROUND An increase in thyroid cancers, predominantly papillary thyroid carcinoma (PTC), ...
The BRAF gene has been shown to be a major target for mutations in papillary thyroid carcinoma (PTC)...
BackgroundWell-differentiated thyroid cancer (WDTC) incidence in pediatrics is rising, most being pa...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Childhood papillary thyroid carcinoma (PTC) diagnosed after the Chernobyl accident in Belarus displa...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Context: BRAF V600E is considered a primary event, a negative prognostic marker, and a site for phar...
International audienceBACKGROUND: Papillary thyroid carcinoma (PTC) in young people usually has an a...
Papillary thyroid cancer (PTC) constitutes more than 90 % of the thyroid cancers. MAP kinase/ERK pat...
Background: Previous studies reported significant differences in the clinical presentation and outco...
The incidence of thyroid carcinoma, mainly of the papillary histological subtype (PTC), has increase...
There has been little understanding of the molecular pathogenesis of pediatric thyroid cancers. Most...
Papillary thyroid carcinoma (PTC) presents distinct clinico-pathological and molecular differences i...
ntroduction: Follicular-derived differentiated thyroid carcinoma (DTC) is the most common endocrine ...
Activating mutations of BRAF have been identified in a variety of human cancers, most notably melano...
none12siBACKGROUND An increase in thyroid cancers, predominantly papillary thyroid carcinoma (PTC), ...
The BRAF gene has been shown to be a major target for mutations in papillary thyroid carcinoma (PTC)...
BackgroundWell-differentiated thyroid cancer (WDTC) incidence in pediatrics is rising, most being pa...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Childhood papillary thyroid carcinoma (PTC) diagnosed after the Chernobyl accident in Belarus displa...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Context: BRAF V600E is considered a primary event, a negative prognostic marker, and a site for phar...
International audienceBACKGROUND: Papillary thyroid carcinoma (PTC) in young people usually has an a...
Papillary thyroid cancer (PTC) constitutes more than 90 % of the thyroid cancers. MAP kinase/ERK pat...